ClinicalTrials.govpublic full text
Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia
aplastic anemia, isatuximab, severe aplastic anemia, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 869013
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.